XRad Therapeutics
New York, US · Founded 2016 · Delaware corporation
Founders & leadership
MK
Michael KastanNamed on SEC filing
AY
Anthony Y. SunNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$498.6K disclosed across 1 round · 2017
▶$498.6KraisedDec 2017 · 1 investors · BiotechnologyRule 506(b)
▶$498.6KraisedDec 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael KastanDirector
- Anthony Y. SunExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $498.6K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has XRad Therapeutics raised?
- XRad Therapeutics has disclosed $498.6K raised across 1 round.
- Where is XRad Therapeutics headquartered?
- XRad Therapeutics is headquartered in New York, US.